![]() The purpose of our study was to compare rates of VTE and major bleeding between rivaroxaban and our previous protocol of enoxaparin after THA/TKA. The oral Factor Xa inhibitor rivaroxaban (Xarelto) has been the pharmacologic agent used for venous thromboembolism(VTE) prophylaxis after primary hip and knee arthroplasty (THA/TKA) at our institution since February 2012. Rivaroxaban Versus Enoxaparin for Venous Thromboembolism Prophylaxis after Hip and Knee Arthroplasty We evaluated demographic data, length of motor blockage, time to ambulation, time to discharge readiness, patient-reported symptoms of TNS. All patients received a single-shot spinal injection, with 2% isobaric lidocaine along with titrated propofol sedation. Methods: We performed a prospective study on 50 patients who received lidocaine spinal anesthesia in the setting of outpatient hip and knee arthroplasty. The purpose of this study is to determine the safety and efficacy of single-dose lidocaine spinal anesthesia in the setting of outpatient joint arthroplasty. However, lidocaine spinal anesthesia has been reported to have a risk of transient neurologic symptoms (TNSs). Lidocaine is a fast-onset, short-duration local anesthetic that has been used for many years in spinal anesthesia. ![]() Single-dose lidocaine spinal anesthesia in hip and knee arthroplastyīackground: With the increasing interest in fast recovery and outpatient joint arthroplasty, short-acting local anesthetic agents and minimal narcotic use are preferred.
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |